Specifically, in breast cancer (BRCA), esophageal cancer (ESCA), glioblastoma (GBM), head and neck cancer (HNSC), low-grade glioma (LGG), liver cancer (LIHC), lung adenocarcinoma (LUAD), cutaneous melanoma (SKCM), and uveal melanoma (UVM), elevated BAP31 levels were correlated with poor overall survival (OS). The gene discussed is BCAP31; the disease is breast carcinoma.